We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
FDA Grants Breakthrough Therapy to Teva for Tardive Dyskinesia Drug
Collegium Wins Tentative Approval for Xtampza ER
FDA Accepts Amgen’s NDA for Etelcalcetide